Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia

Umut Aypar, Stephanie A. Smoley, Beth A. Pitel, Kathryn E. Pearce, Roman M. Zenka, George Vasmatzis, Sarah H. Johnson, James Smadbeck, Jess F. Peterson, Katherine B. Geiersbach, Daniel L. Van Dyke, Erik C Thorland, Robert Brian Jenkins, Rhett P. Ketterling, Patricia T Greipp, Hutton M. Kearney, Nicole L. Hoppman, Linda Baughn

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Acute myeloid leukemia (AML) can be subtyped based on recurrent cytogenetic and molecular genetic abnormalities with diagnostic and prognostic significance. Although cytogenetic characterization classically involves conventional chromosome and/or fluorescence in situ hybridization (FISH) assays, limitations of these techniques include poor resolution and the inability to precisely identify breakpoints. Method: We evaluated whether an NGS-based methodology that detects structural abnormalities and copy number changes using mate pair sequencing (MPseq) can enhance the diagnostic yield for patients with AML. Results: Using 68 known abnormal and 20 karyotypically normal AML samples, each recurrent primary AML-specific abnormality previously identified in the abnormal samples was confirmed using MPseq. Importantly, in eight cases with abnormalities that could not be resolved by conventional cytogenetic studies, MPseq was utilized to molecularly define eight recurrent AML-fusion events. In addition, MPseq uncovered two cryptic abnormalities that were missed by conventional cytogenetic studies. Thus, MPseq improved the diagnostic yield in the detection of AML-specific structural rearrangements in 10/88 (11%) of cases analyzed. Conclusion: Utilization of MPseq represents a precise, molecular-based technique that can be used as an alternative to conventional cytogenetic studies for newly diagnosed AML patients with the potential to revolutionize the diagnosis of hematologic malignancies.

Original languageEnglish (US)
Pages (from-to)87-96
Number of pages10
JournalEuropean Journal of Haematology
Volume102
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Acute Myeloid Leukemia
Cytogenetics
Hematologic Neoplasms
Fluorescence In Situ Hybridization
Molecular Biology
Chromosomes

Keywords

  • acute myeloid leukemia
  • molecular cytogenetics
  • MPseq

ASJC Scopus subject areas

  • Hematology

Cite this

Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia. / Aypar, Umut; Smoley, Stephanie A.; Pitel, Beth A.; Pearce, Kathryn E.; Zenka, Roman M.; Vasmatzis, George; Johnson, Sarah H.; Smadbeck, James; Peterson, Jess F.; Geiersbach, Katherine B.; Van Dyke, Daniel L.; Thorland, Erik C; Jenkins, Robert Brian; Ketterling, Rhett P.; Greipp, Patricia T; Kearney, Hutton M.; Hoppman, Nicole L.; Baughn, Linda.

In: European Journal of Haematology, Vol. 102, No. 1, 01.01.2019, p. 87-96.

Research output: Contribution to journalArticle

Aypar, U, Smoley, SA, Pitel, BA, Pearce, KE, Zenka, RM, Vasmatzis, G, Johnson, SH, Smadbeck, J, Peterson, JF, Geiersbach, KB, Van Dyke, DL, Thorland, EC, Jenkins, RB, Ketterling, RP, Greipp, PT, Kearney, HM, Hoppman, NL & Baughn, L 2019, 'Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia', European Journal of Haematology, vol. 102, no. 1, pp. 87-96. https://doi.org/10.1111/ejh.13179
Aypar, Umut ; Smoley, Stephanie A. ; Pitel, Beth A. ; Pearce, Kathryn E. ; Zenka, Roman M. ; Vasmatzis, George ; Johnson, Sarah H. ; Smadbeck, James ; Peterson, Jess F. ; Geiersbach, Katherine B. ; Van Dyke, Daniel L. ; Thorland, Erik C ; Jenkins, Robert Brian ; Ketterling, Rhett P. ; Greipp, Patricia T ; Kearney, Hutton M. ; Hoppman, Nicole L. ; Baughn, Linda. / Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia. In: European Journal of Haematology. 2019 ; Vol. 102, No. 1. pp. 87-96.
@article{a9de969f1233404ba599e0e31b9f7ab9,
title = "Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia",
abstract = "Objective: Acute myeloid leukemia (AML) can be subtyped based on recurrent cytogenetic and molecular genetic abnormalities with diagnostic and prognostic significance. Although cytogenetic characterization classically involves conventional chromosome and/or fluorescence in situ hybridization (FISH) assays, limitations of these techniques include poor resolution and the inability to precisely identify breakpoints. Method: We evaluated whether an NGS-based methodology that detects structural abnormalities and copy number changes using mate pair sequencing (MPseq) can enhance the diagnostic yield for patients with AML. Results: Using 68 known abnormal and 20 karyotypically normal AML samples, each recurrent primary AML-specific abnormality previously identified in the abnormal samples was confirmed using MPseq. Importantly, in eight cases with abnormalities that could not be resolved by conventional cytogenetic studies, MPseq was utilized to molecularly define eight recurrent AML-fusion events. In addition, MPseq uncovered two cryptic abnormalities that were missed by conventional cytogenetic studies. Thus, MPseq improved the diagnostic yield in the detection of AML-specific structural rearrangements in 10/88 (11{\%}) of cases analyzed. Conclusion: Utilization of MPseq represents a precise, molecular-based technique that can be used as an alternative to conventional cytogenetic studies for newly diagnosed AML patients with the potential to revolutionize the diagnosis of hematologic malignancies.",
keywords = "acute myeloid leukemia, molecular cytogenetics, MPseq",
author = "Umut Aypar and Smoley, {Stephanie A.} and Pitel, {Beth A.} and Pearce, {Kathryn E.} and Zenka, {Roman M.} and George Vasmatzis and Johnson, {Sarah H.} and James Smadbeck and Peterson, {Jess F.} and Geiersbach, {Katherine B.} and {Van Dyke}, {Daniel L.} and Thorland, {Erik C} and Jenkins, {Robert Brian} and Ketterling, {Rhett P.} and Greipp, {Patricia T} and Kearney, {Hutton M.} and Hoppman, {Nicole L.} and Linda Baughn",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/ejh.13179",
language = "English (US)",
volume = "102",
pages = "87--96",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia

AU - Aypar, Umut

AU - Smoley, Stephanie A.

AU - Pitel, Beth A.

AU - Pearce, Kathryn E.

AU - Zenka, Roman M.

AU - Vasmatzis, George

AU - Johnson, Sarah H.

AU - Smadbeck, James

AU - Peterson, Jess F.

AU - Geiersbach, Katherine B.

AU - Van Dyke, Daniel L.

AU - Thorland, Erik C

AU - Jenkins, Robert Brian

AU - Ketterling, Rhett P.

AU - Greipp, Patricia T

AU - Kearney, Hutton M.

AU - Hoppman, Nicole L.

AU - Baughn, Linda

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Acute myeloid leukemia (AML) can be subtyped based on recurrent cytogenetic and molecular genetic abnormalities with diagnostic and prognostic significance. Although cytogenetic characterization classically involves conventional chromosome and/or fluorescence in situ hybridization (FISH) assays, limitations of these techniques include poor resolution and the inability to precisely identify breakpoints. Method: We evaluated whether an NGS-based methodology that detects structural abnormalities and copy number changes using mate pair sequencing (MPseq) can enhance the diagnostic yield for patients with AML. Results: Using 68 known abnormal and 20 karyotypically normal AML samples, each recurrent primary AML-specific abnormality previously identified in the abnormal samples was confirmed using MPseq. Importantly, in eight cases with abnormalities that could not be resolved by conventional cytogenetic studies, MPseq was utilized to molecularly define eight recurrent AML-fusion events. In addition, MPseq uncovered two cryptic abnormalities that were missed by conventional cytogenetic studies. Thus, MPseq improved the diagnostic yield in the detection of AML-specific structural rearrangements in 10/88 (11%) of cases analyzed. Conclusion: Utilization of MPseq represents a precise, molecular-based technique that can be used as an alternative to conventional cytogenetic studies for newly diagnosed AML patients with the potential to revolutionize the diagnosis of hematologic malignancies.

AB - Objective: Acute myeloid leukemia (AML) can be subtyped based on recurrent cytogenetic and molecular genetic abnormalities with diagnostic and prognostic significance. Although cytogenetic characterization classically involves conventional chromosome and/or fluorescence in situ hybridization (FISH) assays, limitations of these techniques include poor resolution and the inability to precisely identify breakpoints. Method: We evaluated whether an NGS-based methodology that detects structural abnormalities and copy number changes using mate pair sequencing (MPseq) can enhance the diagnostic yield for patients with AML. Results: Using 68 known abnormal and 20 karyotypically normal AML samples, each recurrent primary AML-specific abnormality previously identified in the abnormal samples was confirmed using MPseq. Importantly, in eight cases with abnormalities that could not be resolved by conventional cytogenetic studies, MPseq was utilized to molecularly define eight recurrent AML-fusion events. In addition, MPseq uncovered two cryptic abnormalities that were missed by conventional cytogenetic studies. Thus, MPseq improved the diagnostic yield in the detection of AML-specific structural rearrangements in 10/88 (11%) of cases analyzed. Conclusion: Utilization of MPseq represents a precise, molecular-based technique that can be used as an alternative to conventional cytogenetic studies for newly diagnosed AML patients with the potential to revolutionize the diagnosis of hematologic malignancies.

KW - acute myeloid leukemia

KW - molecular cytogenetics

KW - MPseq

UR - http://www.scopus.com/inward/record.url?scp=85058078419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058078419&partnerID=8YFLogxK

U2 - 10.1111/ejh.13179

DO - 10.1111/ejh.13179

M3 - Article

VL - 102

SP - 87

EP - 96

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 1

ER -